The team further demonstrated that KC CD36 phagocytosed modified lipids (eg, oxidized low-density lipoprotein, oxLDL), resulting in cholesterol accumulation in lysosomes and causing liver inflammation, thereby elevating the risk of NASH.38 Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.